Not exact matches
Research demonstrates that blocking the action of two pro-inflammatory molecules significantly
reduces symptoms of allergic
asthma in mice, which could lead to development of a new treatment for people with a
severe form of the condition.
The rate in people with moderate - to -
severe asthma taking the medication was
reduced from an average of 5.4 percent to 1.1 percent over 12 weeks, according to the study published today in the The Lancet Respiratory Medicine journal.
March 16, 2006 Clinical trial measures ability of focused heat treatment to
reduce asthma symptoms The University of Chicago Hospitals is one of about 30 centers around the world, and the only one in Illinois, participating in the Asthma Interventional Research 2 (AIR2) clinical trial, the first U.S. trial of «Bronchial Thermoplasty,» an experimental treatment for patients with moderate to severe a
asthma symptoms The University of Chicago Hospitals is one of about 30 centers around the world, and the only one in Illinois, participating in the
Asthma Interventional Research 2 (AIR2) clinical trial, the first U.S. trial of «Bronchial Thermoplasty,» an experimental treatment for patients with moderate to severe a
Asthma Interventional Research 2 (AIR2) clinical trial, the first U.S. trial of «Bronchial Thermoplasty,» an experimental treatment for patients with moderate to
severe asthmaasthma.
New therapies for
severe asthma, particularly treatments that
reduce exacerbations, remain a significant unmet medical need.
«Recent clinical trials in
severe asthma patients using antibodies that block IL4Ra have shown positive results leading to marked improvement of lung function, improved symptoms and
reduced use of oral steroids,» Professor Anderson said.
One study looked at red ginseng's ability to
reduce allergy - induced nasal inflammation along with subsequent symptoms such as sneezing, runny nose, itching, and even more
severe conditions like
asthma.